ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Nov 23, 2015
Insider Transaction Report
Form 4
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-11-19−153,333→ 76,667 totalExercise: $2.30Exp: 2023-06-26→ Common Stock (153,333 underlying) - Exercise/Conversion
Common Stock
2015-11-19$2.30/sh+153,333$352,666→ 212,534 total - Sale
Common Stock
2015-11-19$12.84/sh−153,333$1,968,796→ 59,201 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.70 to $12.99, inclusive. The reporting person undertakes to provide to ZIOPHARM Oncology, Inc., any security holder of ZIOPHARM Oncology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- [F2]The option is vested with respect to 153,333 shares; the option vests with respect to the remaining 76,667 shares on 6/27/2016.